financetom
Business
financetom
/
Business
/
United Airlines suspends flights to Tel Aviv
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
United Airlines suspends flights to Tel Aviv
Jul 31, 2024 12:19 PM

CHICAGO (Reuters) - United Airlines said on Wednesday it has suspended its flights to Tel Aviv due to security reasons.

The Chicago-based airline said it is evaluating its next steps.

"We continue to closely monitor the situation and will make decisions on resuming service with a focus on the safety of our customers and crews," it said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Globalstar Insider Sold Shares Worth $1,869,086, According to a Recent SEC Filing
Globalstar Insider Sold Shares Worth $1,869,086, According to a Recent SEC Filing
Sep 25, 2025
05:57 PM EDT, 09/25/2025 (MT Newswires) -- Paul E Jacobs, Director, Chief Executive Officer, on September 24, 2025, sold 53,479 shares in Globalstar ( GSAT ) for $1,869,086. Following the Form 4 filing with the SEC, Jacobs has control over a total of 1,175,295 common shares of the company, with 58,895 shares held directly and 1,116,400 controlled indirectly. SEC Filing:...
Kura, Kyowa Kirin Report Ziftomenib Met Primary Endpoint in Phase 2 Leukemia Trial
Kura, Kyowa Kirin Report Ziftomenib Met Primary Endpoint in Phase 2 Leukemia Trial
Sep 25, 2025
05:57 PM EDT, 09/25/2025 (MT Newswires) -- Kura Oncology ( KURA ) and Kyowa Kirin said Thursday the investigational menin inhibitor ziftomenib met its primary endpoint in the phase 2 Komet-001 trial in adults with relapsed or refractory NPM1-mutated acute myeloid leukemia. Ziftomenib monotherapy produced a 22% complete remission with full or partial hematologic recovery rate compared with the 12%...
N2OFF Shareholders Approve Acquisition of MitoCareX Bio
N2OFF Shareholders Approve Acquisition of MitoCareX Bio
Sep 25, 2025
05:59 PM EDT, 09/25/2025 (MT Newswires) -- N2OFF ( NITO ) shareholders approved the acquisition of MitoCareX Bio, a biotechnology company developing treatments for difficult-to-treat cancers. In February, N2OFF ( NITO ) agreed to acquire MitoCareX from SciSparc ( SPRC ) and other sellers for $700,000 in cash and up to 65% of its fully diluted common stock through share...
BRIEF-N2off Stockholders Approve Merger With Drug Discovery Company Targeting Resistant Cancers Including Pancreatic And Non-Small Cell Lung Cancer
BRIEF-N2off Stockholders Approve Merger With Drug Discovery Company Targeting Resistant Cancers Including Pancreatic And Non-Small Cell Lung Cancer
Sep 25, 2025
Sept 25 (Reuters) - N2OFF Inc ( NITO ): * N2OFF STOCKHOLDERS APPROVE MERGER WITH DRUG DISCOVERY COMPANY TARGETING RESISTANT CANCERS INCLUDING PANCREATIC AND NON-SMALL CELL LUNG CANCER Source text: Further company coverage: ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved